Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia

American Journal of Emergency Medicine

Volumn 31, Issue 1, 2013, Pages 215-221

  Courtais, Caroline ^a   Kuster, Nils ^a   Dupuy, Anne Marie ^a   Folschveiller, Margit ^a   Jreige, Riad ^a   Bargnoux, Anne Sophie ^a   Guiot, Julie ^a   Lefebvre, Sophie ^a   Cristol, Jean Paul ^a   Sebbane, Mustapha ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROADRENOMEDULLIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PNEUMONIA SEVERITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADRENOMEDULLIN; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84870937155     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2012.07.017     Document Type: Article

References (28)

1. E. Polverino, and A. Torres Marti Community-acquired pneumonia Minerva Anestesiol 77 2011 196 211
2. L. Vivès, P. Biel, and G. Maler Acute community-acquired pneumonia of moderate and grave severity investigated by bronchoscopy. Analysis of 193 cases hospitalized in a general hospital Rev Mal Respir 13 1996 175 182
3. M.J. Fine, L.J. Hough, and A.R. Medsger The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study Arch Intern Med 157 1997 36 44
4. A. Singanayagam, J.D. Chalmers, and A.T. Hill Severity assessment in community-acquired pneumonia: a review QJM 102 2009 379 388
5. W.S. Lim, M.M. van der Eerden, and R. Laing Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 2003 377 382
6. W. Lim, J. Macfarlane, and T. Boswell Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines Thorax 56 2001 296 301
7. R. Menéndez, R. Martínez, and S. Reyes Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia Thorax 64 2009 587 591
8. M. Christ-Crain, N.G. Morgenthaler, and D. Stolz Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397] Crit Care 10 2006 R96
9. D.T. Huang, D.C. Angus, and J.A. Kellum Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia Chest 136 2009 823 831
10. P. Schuetz, M. Wolbers, and M. Christ-Crain Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections Crit Care 14 2010 R106
11. W.K. Samson Proadrenomedullin-derived peptides Front Neuroendocrinol 19 1998 100 127
12. K.L. Becker, E.S. Nylén, and J.C. White Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors J Clin Endocrinol Metabol 89 2004 1512 1525
13. Y. Hirata, C. Mitaka, and K. Sato Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis J Clin Endocrinol Metabol 81 1996 1449 1453
14. T. Nishikimi, K. Kitamura, and Y. Saito Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects Hypertension 24 1994 600 604
15. M. Christ-Crain, N.G. Morgenthaler, and J. Struck Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study Crit Care 9 2005 R816 R824
16. A. Vassault, M. Baud, and M. Castanier Recommendations for a comparison of techniques Ann Biol Clin 50 1992 727 730
17. E.R. DeLong, W.B. Vernon, and R.R. Bollinger Sensitivity and specificity of a monitoring test Biometrics 41 1985 947 958
18. M. Pencina, R. D'Agostino, and R. Vasan Statistical methods for assessment of added usefulness of new biomarkers Clin Chem Lab Med 48 2010 1703 1711
19. D. Aujesky, and M.J. Fine The Pneumonia Severity Index: a decade after the initial derivation and validation Clin Infect Dis 47 2008 S133 S139
20. J. Metlay, and M. Fine Testing strategies in the initial management of patients with community-acquired pneumonia Ann Intern Med 138 2003 109 118
21. P. Krueger, M. Loeb, and C. Kelly Assessing, treating and preventing community acquired pneumonia in older adults: findings from a community-wide survey of emergency room and family physicians BMC Fam Pract 6 2005 32
22. Y.K. Loke, C.S. Kwok, and A. Niruban Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis Thorax 65 2010 884 890
23. S. Bello, A.B. Lasierra, and E. Mincholé Prognostic power of proadrenomedullin in community-acquired pneumonia is independent on etiology Eur Respir J 2011
24. S. Krüger, S. Ewig, and S. Giersdorf Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ Am J Respir Crit Care Med 182 2010 1426 1434
25. B. Renaud, P. Schuetz, and Y-E. Claessens Proadrenomedullin improves REA-ICU score for predicting Early Severe Community-Acquired Pneumonia Chest 2012 In Press 10.1378/chest.11-2574
26. W.C. Albrich, F. Dusemund, and K. Rüegger Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm BMC Infect Dis 11 2011 112
27. B. Suberviola, A. Castellanos-Ortega, and J. Llorca Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia Swiss Med Wkly 142 2012 w13542
28. A. Maisel, C. Mueller, and R.M. Nowak Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial J Am Coll Cardiol 58 2011 1057 1067